earnings
confidence high
sentiment neutral
materiality 0.90
Perrigo Reports Q1 2024 Adjusted EPS of $0.29, Above Projection; Net Sales Down 8.4%
PERRIGO Co plc
2024-Q1 EPS reported
$0.01
revenue$1,082,100,000
- Q1 net sales $1.1B, down 8.4% vs prior year; organic net sales declined 7.0% due to infant formula and SKU prioritization actions.
- Adjusted diluted EPS of $0.29, $0.06 ahead of projection primarily from infant formula shipment timing; down from $0.45 YoY.
- Reaffirms FY2024 outlook: organic sales growth 1%-3%, adjusted EPS range $2.50-$2.65, interest expense ~$180M.
- Infant formula impacted adjusted gross margin by -280 bps and adjusted EPS by -$0.30 in the quarter.
- Svend Andersen, EVP & President CSCI, to retire; Roberto Khoury appointed as successor effective August 1, 2024.